High expression of microRNA-210 is an independent factor indicating a poor prognosis in Japanese triple-negative breast cancer patients.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Japanese Journal of Clinical Oncology

• Publication date

  2012-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/jjco/hys001PMID 22323552
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

  2011cited by this paper
• miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity

  2011cited by this paper
• Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial.

  2010cited by this paper
• MicroRNA‐15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma

  2010cited by this paper
• MicroRNA-210 Regulates Mitochondrial Free Radical Response to Hypoxia and Krebs Cycle in Cancer Cells by Targeting Iron Sulfur Cluster Protein ISCU

  2010influential reference
• Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival

  2010cited by this paper
• Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression

  2010cited by this paper
• Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas

  2010cited by this paper
• MiR-210--micromanager of the hypoxia pathway.

  2010cited by this paper
• hsa‐miR‐210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer

  2010cited by this paper
• Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.

  2010cited by this paper
• Identification of a microRNA panel for clear-cell kidney cancer.

  2010cited by this paper
• MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2.

  2009cited by this paper
• MicroRNA regulation of DNA repair gene expression in hypoxic stress.

  2009influential reference
• miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer.

  2009cited by this paper
• Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation.

  2009influential reference
• Hypoxia-inducible factors in stem cells and cancer

  2009influential reference
• MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT

  2009influential reference
• Small non-coding RNAs in animal development

  2008cited by this paper
• Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

  2008cited by this paper
• Basal-like breast cancer: a critical review.

  2008cited by this paper
• hsa-miR-210 Is Induced by Hypoxia and Is an Independent Prognostic Factor in Breast Cancer

  2008influential reference
• Brick by brick: metabolism and tumor cell growth.

  2008cited by this paper
• Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer

  2008influential reference
• MicroRNA-210 Modulates Endothelial Cell Response to Hypoxia and Inhibits the Receptor Tyrosine Kinase Ligand Ephrin-A3*

  2008cited by this paper
• Hypoxia, HIF1 and glucose metabolism in the solid tumour

  2008influential reference
• Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers

  2008influential reference
• Mechanisms of microRNA‐mediated gene regulation

  2007influential reference
• A MicroRNA Signature of Hypoxia

  2006cited by this paper
• Oncomirs — microRNAs with a role in cancer

  2006cited by this paper
• Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs

  2005cited by this paper
• Mitochondrial tumour suppressors: a genetic and biochemical update

  2005cited by this paper
• Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

  2004cited by this paper
• Repeated observation of breast tumor subtypes in independent gene expression data sets

  2003cited by this paper
• Expert Commentary.

  2002cited by this paper
• Pathological prognostic factors in breast cancer.

  1999cited by this paper
• Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

  1999cited by this paper
• Analysis of the effects of oxygen supply and demand on hypoxic fraction in tumors.

  1995cited by this paper
• pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

  1991cited by this paper

• HypoxamiRs: the hidden architects of tissue adaptation in hypoxia

  2025cites this paper
• The role of microRNAs in breast cancer: Diagnostic and therapeutic implications.

  2025cites this paper
• Functions of Differentially Regulated miRNAs in Breast Cancer Progression: Potential Markers for Early Detection and Candidates for Therapy

  2024cites this paper
• Hypoxia-driven ncRNAs in breast cancer

  2023cites this paper
• The dual role of MiR-210 in the aetiology of cancer: A focus on hypoxia-inducible factor signalling.

  2023cites this paper
• Serum microRNA-210 as a predictor of neoadjuvant chemotherapy resistance in breast cancer

  2023cites this paper
• Hypoxia-induced autophagy in triple negative breast cancer: association with prognostic variables, patients’ survival and response to neoadjuvant chemotherapy

  2023cites this paper
• Prognostic and Predictive Biomarkers in Familial Breast Cancer

  2023cites this paper
• Conducive target range of breast cancer: Hypoxic tumor microenvironment

  2022cites this paper
• The Role of miRNAs in the Prognosis of Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis

  2022cites this paper
• Discovering the Triad between Nav1.5, Breast Cancer, and the Immune System: A Fundamental Review and Future Perspectives

  2022cites this paper
• miR-210 Expression Is Strongly Hypoxia-Induced in Anaplastic Thyroid Cancer Cell Lines and Is Associated with Extracellular Vesicles and Argonaute-2

  2022cites this paper
• Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer

  2021cites this paper
• Clinical Identification of Dysregulated Circulating microRNAs and Their Implication in Drug Response in Triple Negative Breast Cancer (TNBC) by Target Gene Network and Meta-Analysis

  2021cites this paper
• Expression and clinical prognostic value of m6A RNA methylation modification in breast cancer

  2021cites this paper
• Clinical Identification of Dysregulated Circulating microRNAs and Their Implication in Drug Response in Triple Negative Breast Cancer (TNBC) by Target Gene Network and Meta-Analysis

  2021cites this paper
• Updated review on green tea polyphenol epigallocatechin-3-gallate as a cancer epigenetic regulator.

  2021cites this paper
• The interplay between HIF-1α and noncoding RNAs in cancer

  2020cites this paper
• Expression of miR-34a is a sensitive biomarker for exposure to genotoxic agents in human lymphoblastoid TK6 cells.

  2020cites this paper
• [MicroRNA-671-3p suppresses proliferation and invasion of breast cancer cells by targeting DEPTOR].

  2020cites this paper
• Emergence of Circulating MicroRNAs in Breast Cancer as Diagnostic and Therapeutic Efficacy Biomarkers

  2020cites this paper
• Expressions of miR-21 and miR-210 in Breast Cancer and Their Predictive Values for Prognosis

  2020cites this paper
• MicroRNA-based potential diagnostic, prognostic and therapeutic applications in triple-negative breast cancer

  2019cites this paper
• Prognostic role of microRNAs in breast cancer: A systematic review

  2019cites this paper
• Mechanism of miR-210 involved in epithelial–mesenchymal transition of pancreatic cancer cells under hypoxia

  2019cites this paper
• MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance, and Applications in Human Triple-Negative Breast Cancer

  2019cites this paper
• MicroRNAs in breast cancer: Roles, functions, and mechanism of actions

  2019influential citation
• MiR-942 regulates the function of breast cancer cell by targeting FOXA2

  2019cites this paper
• Integrated copy number and miRNA expression analysis in triple negative breast cancer of Latin American patients

  2019cites this paper
• Hsa-miR-210-3p expression in breast cancer and its putative association with worse outcome in patients treated with Docetaxel

  2019cites this paper
• Chapter 3 Gene Silencing Agents in Breast Cancer

  2019cites this paper
• Provisional chapter Gene Silencing Agents in Breast Cancer

  2019cites this paper
• Plasma microRNAs Predict Chemoresistance in Patients With Metastatic Breast Cancer

  2019cites this paper
• Aberrant miRNAs expressed in HER-2 negative breast cancers patient

  2018cites this paper
• Novel prognostic and predictive microRNA targets for triple‐negative breast cancer

  2018cites this paper
• Effects of microRNA‑210 on the diagnosis and treatment of prostate cancer.

  2018cites this paper
• MiR-128 promotes the apoptosis of glioma cells via binding to NEK2.

  2018cites this paper
• MiR-210 knockdown promotes the development of pancreatic cancer via upregulating E2F3 expression.

  2018cites this paper
• Gene Silencing Agents in Breast Cancer

  2018cites this paper
• Circulating miRNAs Increasing the Risk of Cancer

  2018cites this paper
• PROGNOSTIC IMPACT OF MICRORNA EXPRESSION IN BREAST CANCER

  2018cites this paper
• Genome-scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma

  2018cites this paper
• MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction

  2017cites this paper
• The MicroRNA miR-210 Is Expressed by Cancer Cells but Also by the Tumor Microenvironment in Triple-Negative Breast Cancer

  2017cites this paper
• MiRNAs Predict the Prognosis of Patients with Triple Negative Breast Cancer: A Meta-Analysis

  2017cites this paper
• MicroRNAs in the prognosis of triple-negative breast cancer

  2017cites this paper
• MiRNA-210: A Current Overview.

  2017cites this paper
• The Role of MicroRNAs in Diagnosis, Prognosis, Metastasis and Resistant Cases in Breast Cancer.

  2017cites this paper
• Robust expression of tumor suppressor miRNA’s let-7 and miR-195 detected in plasma of Saudi female breast cancer patients

  2017cites this paper
• Prognostic evaluation of microRNA-210 in various carcinomas

  2017cites this paper
• The roles of ncRNAs in the diagnosis, prognosis and clinicopathological features of breast cancer: a systematic review and meta-analysis

  2017cites this paper
• microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer

  2016cites this paper
• Deregulated miRNAs in Triple Negative Breast Cancer

  2016cites this paper
• Potential biomarker panels in overall breast cancer management: advancements by multilevel diagnostics.

  2016cites this paper
• Differentially expressed miRNAs in triple negative breast cancer between African-American and non-Hispanic white women

  2016cites this paper
• Novel insight into triple-negative breast cancers, the emerging role of angiogenesis, and antiangiogenic therapy

  2016cites this paper
• Triple-negative breast cancer: investigating potential molecular therapeutic target

  2015cites this paper
• Hypoxia in breast cancer.

  2015cites this paper
• Antioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem Cells

  2015cites this paper
• Roles of microRNAs in diseases of the human gastrointestinal tract

  2015cites this paper
• miR-210 as a Biomarker in Renal Carcinoma

  2015cites this paper
• MiRNA and Target Oncogene Regulation in Triple Negative Breast Cancer : An Age , Ethnic and Environmental Related Neoplastic Event

  2015cites this paper
• MIR210 as a potential molecular target to block invasion and metastasis of gastric cancer.

  2015cites this paper
• Identification of dysregulated microRNAs in triple-negative breast cancer (review).

  2015cites this paper
• miRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer

  2015cites this paper
• Critical analysis of the potential for microRNA biomarkers in breast cancer management

  2015cites this paper
• Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring

  2015cites this paper
• Prognostic role of microRNA-210 in various carcinomas: a meta-analysis.

  2015cites this paper
• High expression of miR-214 is associated with a worse disease-specific survival of the triple-negative breast cancer patients

  2015cites this paper
• MicroRNAs-mediated cell fate in triple negative breast cancers.

  2015cites this paper
• High Expression Levels of miR-21 and miR-210 Predict Unfavorable Survival in Breast Cancer: A Systemic Review and Meta-Analysis

  2015cites this paper
• Triple-negative and luminal A breast tumors: differential expression of miR-18a-5p, miR-17-5p, and miR-20a-5p

  2014cites this paper
• Tumor Microenvironment and Cellular Stress

  2014cites this paper
• miR‑210 regulates esophageal cancer cell proliferation by inducing G2/M phase cell cycle arrest through targeting PLK1.

  2014cites this paper
• Elevated Expression of miR-210 Predicts Poor Survival of Cancer Patients: A Systematic Review and Meta-Analysis

  2014influential citation
• MiR-210 expression reverses radioresistance of stem-like cells of oesophageal squamous cell carcinoma.

  2014cites this paper
• Multiple functions of hypoxia-regulated miR-210 in cancer

  2014cites this paper
• World Journal of Clinical Oncology MiR-210 expression reverses radioresistance of stem-like cells of oesophageal squamous cell carcinoma

  2014cites this paper
• Emerging Roles of Non-Coding RNAs in the Hypoxic Response

  2014cites this paper
• DNA methylation and miRNAs regulation in hereditary breast cancer: epigenetic changes, players in transcriptional and post- transcriptional regulation in hereditary breast cancer.

  2014cites this paper
• A Prognostic Model of Triple-Negative Breast Cancer Based on miR-27b-3p and Node Status

  2014cites this paper
• MicroRNAs as regulatory elements in triple negative breast cancer.

  2014cites this paper
• miR-210: fine-tuning the hypoxic response.

  2014cites this paper
• microRNAs: a new class of breast cancer biomarkers

  2014cites this paper
• HypoxamiRs and Cancer: From Biology to Targeted Therapy

  2014cites this paper
• Expression and clinical significance of microRNA-376a in colorectal cancer.

  2014cites this paper
• MicroRNA Expression in Different Sybtypes of Breast Cancer

  2013cites this paper
• Ethnicity modifies the association between functional microRNA polymorphisms and breast cancer risk: a HuGE meta-analysis

  2013cites this paper
• microRNA-210 as a prognostic factor in patients with breast cancer: Meta-analysis

  2013influential citation
• miR-210: a therapeutic target in cancer

  2013cites this paper
• New strategies for targeting the hypoxic tumour microenvironment in breast cancer.

  2013cites this paper
• The prognostic value of miR-21 and miR-155 in non-small-cell lung cancer: a meta-analysis.

  2013cites this paper
• Tumour oxygenation: implications for breast cancer prognosis

  2013cites this paper
• MicroRNAs and Triple Negative Breast Cancer

  2013cites this paper
• Targeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressiveness.

  2013cites this paper
• High expression of miR-210 predicts poor survival in patients with breast cancer: a meta-analysis.

  2012cites this paper
• SPECIALTY EDITORS: MASTOLOGY

  year unknowncites this paper